repression of p73 controls Cisplatin chemoresistance in primary bone tumors
暂无分享,去创建一个
[1] D. Liebner. The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma , 2015, Journal of surgical oncology.
[2] H. Nagase,et al. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity , 2014, The FEBS journal.
[3] Qing Xu,et al. MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells , 2014, Chinese journal of cancer.
[4] Kaishan Liu,et al. p73 expression is associated with cellular chemosensitivity in human non-small cell lung cancer cell lines , 2012, Oncology letters.
[5] Ji-feng Huang,et al. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. , 2012, Oncology letters.
[6] T. Sakai,et al. p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription , 2012, PloS one.
[7] Jing Li,et al. 5-aza-2′-deoxycytidine Increases the Sensitivity of Human Bone Marrow Mesenchymal Stem Cells to Chemotherapeutic Agents by Demethylation of p73 , 2012, Journal of pediatric hematology/oncology.
[8] Hao Zhang,et al. miRNA expression profile during osteogenic differentiation of human adipose‐derived stem cells , 2012, Journal of cellular biochemistry.
[9] F. Sun,et al. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells , 2012, Cancer Chemotherapy and Pharmacology.
[10] C. Croce,et al. Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.
[11] B. Karlan,et al. BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma , 2010 .
[12] M. Kadakia,et al. p73 is essential for vitamin D mediated osteoblastic differentiation , 2009, Cell Death and Differentiation.
[13] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[14] Charles D. Johnson,et al. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. , 2007, Cancer research.
[15] A. Nakagawara,et al. Stabilization of p73 by Nuclear IκB Kinase-α Mediates Cisplatin-induced Apoptosis* , 2007, Journal of Biological Chemistry.
[16] D. Sgroi,et al. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. , 2007, The Journal of clinical investigation.
[17] H. Kovar,et al. Ewing's sarcoma family of tumors: current management. , 2006, The oncologist.
[18] A. Trumpp,et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. , 2005, Cancer research.
[19] M. Gebhardt,et al. Biology and therapeutic advances for pediatric osteosarcoma. , 2004, The oncologist.
[20] U. Moll,et al. p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.
[21] D. Green,et al. p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation* , 2004, Journal of Biological Chemistry.
[22] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[23] A. Sandberg,et al. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. , 2003, Cancer genetics and cytogenetics.
[24] Gideon Rechavi,et al. Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses* , 2002, The Journal of Biological Chemistry.
[25] U. Moll,et al. ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors , 2002, The Journal of experimental medicine.
[26] J. Pelletier,et al. Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.
[27] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[28] A. Sakurada,et al. Infrequent somatic mutations of the p73 gene in various human cancers. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[29] K. Ishizaki,et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. , 1994, Cancer research.
[30] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[31] R. Hanada,et al. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. , 1993, Cancer research.
[32] E. A. Fry,et al. Alterations of p63 and p73 in human cancers. , 2014, Sub-cellular biochemistry.
[33] V. Zajac,et al. Contribution of p53, p63, and p73 to the developmental diseases and cancer. , 2008, Neoplasma.